Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid
Status:
RECRUITING
Trial end date:
2027-08-15
Target enrollment:
Participant gender:
Summary
To explore the efficacy of Houyanqing Oral Liquid combined with conventional treatment in preventing and treating radiation-induced oral mucositis, so as to improve the quality of life of nasopharyngeal carcinoma patients received radiotherapy.
Phase:
PHASE3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University Affiliated Cancer Hospital of Shantou University Medical College Cancer Hospital Chinese Academy of Medical Science Cancer Hospital of Guangxi Medical University Eye & ENT Hospital of Fudan University First Affiliated Hospital of Kunming Medical University Fujian Cancer Hospital Hunan Cancer Hospital Sun Yat-sen University Cancer Centre The Fifth Affiliated Hospital, Sun Yat-sen University The First People's Hospital of Changzhou West China Hospital Wuzhou Red Cross Hospital Xiangya Hospital of Central South University Yunnan Cancer Hospital Zhejiang Cancer Hospital